- Home
- Services
- usa new york
- potential therapeutic
Show results for
Refine by
Potential Therapeutic Services In Usa New York
6 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Rodent disease models are widely used for a broad range of project objectives, which involve investigation of pathological process and mechanism of disease, pre-clinical tests of potential therapeutic agents, ...
by:Bionique Testing Laboratories, Inc. based inSaranac Lake, NEW YORK (USA)
Resistance to antibiotics whether inherent or acquired is a well known characteristic of mycoplasmas. The antibiotic sensitivity profile developed in this assay provides information regarding potential therapeutic agents targeted for an individual. Sample Requirements: Test sample must currently be on test by a direct culture method at ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Primary T cell, as an important class of immune cells system, play an extremely important role in immunity system. It holds great potential for therapeutic applications to engineer genome in primary T cells. However, genome engineering in primary T cells is still a challenge due to low delivery efficiency and limited expression of CRISPR/Cas9 components. In order ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
The field of bioconjugation has had a considerable impact on academic research, clinical diagnostics and the production of therapeutics. Peptides are an important type of molecules for derivatization by bioconjugation. Peptide–drug conjugates hold a promising stance in the delivery of therapeutic agents by providing distinct advantage of improving ...
Manufactured by:Creative BioMart based in, NEW YORK (USA)
Creative Biomart provides drug analysis service for pre-clinical drugs and natural products on their physical and chemical properties. Our services include three main assays: pre-clinical pharmaceutical property analysis, pharmacokinetics analysis & bioanalysis, andnatural product ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Acute Radiation Syndrome (ARS) involves severe, potentially lethal damage to the bone marrow’s ability to produce blood cells, as well as to other systems and organs. Severe damage to bone marrow makes victims vulnerable to life-threatening hemorrhage, infection and anemia. ...